![Arvind Utchanah](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 886 607 $ in data 30/09/2026
Arvind Utchanah is currently Chief Financial Officer at Knight Therapeutics, Inc. since 2020.
Formerly, Mr. Utchanah was Director-Finance, Accounting & Financial Planning at Paladin Labs, Inc. from 2012 to 2016.
Education includes undergraduate studies at McGill University and graduate studies at Concordia University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 15/09/2026 | 118.689 ( 0,12% ) | 886 607 $ | 30/09/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| KNIGHT THERAPEUTICS INC. | Direttore Finanziario/CFO | 30/03/2020 |
| Società | Posizione | Fine |
|---|---|---|
| PALADIN LABS INC. | Direttore Finanziario/CFO | 01/06/2016 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 4 |
|---|---|
Paladin Labs, Inc.
 Paladin Labs, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceuticals | Health Technology |
Knight Therapeutics, Inc.
 Knight Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Acquires, sells and markets prescription and over-the-counter pharmaceutical products | Health Technology |
McGill University
 McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Concordia University
 Concordia University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
